Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220005413 220002116 1.67 80.9 Palliative (P) 2013-07-02 2013-07-02 Trial Unspecified 01 null 220028136 TRIAL
220005414 220011144 1.55 84.8 Disease modification (D) 2014-05-29 2014-06-10 LI-1 TRIAL Y N 220028137 TRIAL
220005415 220011144 null 65 Curative (C) 2013-05-06 2013-05-06 AML17 TRIAL Y null 220028137 AML17 TRIAL
220005416 220002117 1.83 76 Curative (C) 2017-01-25 2017-01-25 AML17 TRIAL 1 null 220028139 AML17 TRIAL
220005417 220002117 1.54 50 Not known (9) 2014-11-18 2014-11-18 AML17 TRIAL null N 220028139 AML17 TRIAL
220005418 220002117 1.66 null Palliative (P) 2013-07-06 2013-07-26 Cytarabine low (10to20mg/m2) IV/SC N N 220028139 CYTARABINE
220005419 220002118 1.7 77.1 Curative (C) 2015-03-11 2015-03-11 Cytarabine Low Dose 2 N 220028146 CYTARABINE
220005420 220002118 0 62 Curative (C) 2015-12-09 2015-12-09 Trial Unspecified N N 220028146 TRIAL
220005421 220002118 1.64 80 Curative (C) 2015-01-30 2015-02-04 AML17 TRIAL 02 N 220028146 AML17 TRIAL
220005422 220002118 1.78 56 Curative (C) 2017-12-22 2017-12-27 Trial Unspecified Y N 220028146 TRIAL
220005423 220002119 1.78 54 Curative (C) 2013-11-20 2014-05-07 AML17 TRIAL Y N 220028151 AML17 TRIAL
220005424 220002120 null 70 Curative (C) 2016-03-29 2016-04-19 LI-1 TRIAL Y N 220028152 TRIAL
220005425 220002120 0 78.1 null 2017-01-02 2017-01-02 AML17 TRIAL Y N 220028152 AML17 TRIAL
220005426 220002120 1.63 99 Curative (C) null 2016-11-30 AML17 TRIAL null null 220028152 AML17 TRIAL
220005427 220018746 1.78 51.5 Palliative (P) 2017-07-10 2017-07-17 CYTARABINE 2 N 220028164 CYTARABINE
220005428 220018746 1.82 88 Curative (C) 2016-05-14 2016-05-14 AML17 TRIAL N N 220028164 AML17 TRIAL
220005429 220018746 0 null null 2016-10-15 2016-10-26 CYTARABINE N N 220028164 CYTARABINE
220005430 220021712 null 81.5 Disease modification (D) 2017-05-13 2017-05-20 Cytarabine Low Dose N N 220028169 CYTARABINE
220005431 220021712 1.67 67.2 Curative (C) 2013-04-19 2013-04-19 AML17 TRIAL 01 N 220028169 AML17 TRIAL
220005432 220002121 null 78.9 Palliative (P) 2013-12-25 2013-12-27 CYTARABINE 2 N 220028172 CYTARABINE
220005433 220002121 1.58 80 Curative (C) 2014-05-16 2014-05-16 AML17 TRIAL 1 N 220028172 AML17 TRIAL
220005436 220002123 null 84 Curative (C) 2017-06-14 2017-06-14 AML17 TRIAL 01 N 220028180 AML17 TRIAL
220005437 220011150 null 62.3 Palliative (P) 2013-03-08 2013-03-09 Cytarabine low (10to20mg/m2) IV/SC N N 220028182 CYTARABINE
220005438 220011150 1.71 86.1 Curative (C) 2013-05-24 2013-05-24 Trial Unspecified Y N 220028182 TRIAL
220005439 220002124 1.71 54 Curative (C) 2013-09-26 2013-10-07 AML17 TRIAL N N 220028184 AML17 TRIAL
220005440 220002125 1.57 null Curative (C) 2017-10-18 2017-10-29 LI-1 TRIAL N N 220028186 TRIAL
220005441 220011151 1.56 55.8 Palliative (P) null 2017-09-16 CYTARABINE 2 N 220028187 CYTARABINE
220005442 220002126 1.8 0 Curative (C) 2014-02-19 2014-02-19 LI-1 TRIAL 1 N 220028190 TRIAL
220005443 220002127 1.62 81 Palliative (P) 2014-04-15 2014-04-15 Cytarabine Low Dose 2 N 220028191 CYTARABINE
220005444 220011152 1.81 73.899 Curative (C) 2013-10-01 2013-10-01 AML17 TRIAL 01 N 220028195 AML17 TRIAL
220005445 220011152 1.63 91.8 Curative (C) 2014-06-29 2014-06-29 AML17 TRIAL Y N 220028195 AML17 TRIAL
220005446 220002128 1.81 65.4 Radical (R) 2015-01-27 2015-01-27 AML17 TRIAL N N 220028201 AML17 TRIAL
220005447 220002128 null 64.1 Disease modification (D) 2015-09-08 2015-09-08 Trial Unspecified Y null 220028201 TRIAL
220005448 220002128 1.63 82.3 Curative (C) 2017-05-15 2017-05-22 AML17 TRIAL Y N 220028201 AML17 TRIAL
220005449 220002129 1.61 110 Curative (C) 2013-05-31 2013-05-31 LI-1 TRIAL Y N 220028207 TRIAL
220005450 220011154 1.51 0 Palliative (P) 2015-01-31 2016-01-31 CYTARABINE N N 220028209 CYTARABINE
220005451 220002130 1.69 0 null 2014-03-23 2014-03-26 CYTARABINE N N 220028211 CYTARABINE
220005452 220002131 1.78 62 Curative (C) 2014-01-15 2014-01-15 CYTARABINE N N 220028213 CYTARABINE
220005453 220002131 1.82 66.8 Curative (C) 2016-12-18 2016-12-18 LI-1 TRIAL 01 N 220028213 TRIAL
220005454 220002132 1.85 null Curative (C) 2016-11-08 2016-12-17 AML17 TRIAL Y N 220028217 AML17 TRIAL
220005455 220002133 1.7 null Palliative (P) 2016-03-02 2016-03-02 Cytarabine Low Dose 1 null 220028219 CYTARABINE
220005456 220002134 null 106.3 Disease modification (D) 2015-01-25 2015-01-25 Trial Unspecified Y N 220028220 TRIAL
220005457 220002134 1.69 86.5 Not known (9) 2017-01-05 2017-01-05 AML17 TRIAL N N 220028220 AML17 TRIAL
220005458 220002135 1.7 null Curative (C) 2015-02-22 2015-02-22 AML17 TRIAL 01 N 220028227 AML17 TRIAL
220005459 220002135 1.75 97.3 Adjuvant (A) 2017-08-07 2017-08-07 AML17 TRIAL 02 N 220028227 AML17 TRIAL
220005460 220015973 1.53 82 Curative (C) 2016-10-13 2016-10-14 LI-1 TRIAL 1 null 220028229 TRIAL
220005461 220002136 1.76 79.9 Curative (C) 2016-12-06 2016-12-07 AML17 TRIAL N N 220028231 AML17 TRIAL
220005462 220002136 1.47 75 Curative (C) 2016-10-21 2016-10-23 AML17 TRIAL 02 N 220028231 AML17 TRIAL
220005463 220002136 0 null Curative (C) 2015-01-25 2015-01-25 LI-1 TRIAL Y N 220028231 TRIAL
220005464 220018747 1.62 null Disease modification (D) null 2014-06-29 Cytarabine low (10to20mg/m2) IV/SC null null 220028243 CYTARABINE